Frémond, Marie-Louise http://orcid.org/0000-0002-2798-9141
Hully, Marie
Fournier, Benjamin
Barrois, Rémi
Lévy, Romain
Aubart, Mélodie
Castelle, Martin
Chabalier, Delphine
Gins, Clarisse
Sarda, Eugénie
Al Adba, Buthaina
Couderc, Sophie
D’ Almeida, Céline
Berat, Claire-Marine
Durrleman, Chloé
Espil, Caroline
Lambert, Laetitia
Méni, Cécile
Périvier, Maximilien
Pillet, Pascal
Polivka, Laura
Schiff, Manuel
Todosi, Calina
Uettwiller, Florence
Lepelley, Alice
Rice, Gillian I.
Seabra, Luis
Sanquer, Sylvia
Hulin, Anne
Pressiat, Claire
Goldwirt, Lauriane
Bondet, Vincent
Duffy, Darragh
Moshous, Despina
Bader-Meunier, Brigitte
Bodemer, Christine
Robin-Renaldo, Florence
Boddaert, Nathalie
Blanche, Stéphane
Desguerre, Isabelle
Crow, Yanick J.
Neven, Bénédicte
Article History
Received: 5 December 2022
Accepted: 19 April 2023
First Online: 12 May 2023
Declarations
:
: Consent of the parents was obtained for conducting the measurement of ISGs expression and interferon alpha protein levels, as part of the study approved by the Comité de protection des personnes Ile de France II and the French advisory committee on data processing in medical research (ID-RCB: 2014-A01017-40).
: Off-label treatment with ruxolitinib or baricitinib was initiated with parental written consent.
: Written informed consent was obtained for pictures appearing in the manuscript.
: Y. J. C. acts as a scientific advisor for Related Sciences. M.-L. F. and Y. J. C. have undertaken consultancy work for Biogen on behalf of the University of Edinburgh and the Institute Imagine.
: The patients and public were not involved in clinical research or co-production of research.